Journals / Ege Tıp Dergisi / 2015 / Cilt: 54 - Sayı: 2

Inci dence and clinical importance of prostate cancer in patients who underwent radical cystoprostatectomy

Radikal sistoprostatektomi yapılan hastalarda prostat kanseri insidansı ve klinik önemi

Pages
65–69
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The high coincidence of bladder and prostate cancers should be kept in mind, careful and detailed pathological examinations are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Incidental prostate adenocarcinomas which are detected in radical cystoprostatectomy (RCP) specimens are generally localized, well differentiated and have no clinical importance.
📊
Key Findings & Data:In this study, we aimed to determine the rate of incidental prostate adenocarcinoma in patients underwent RCP and assess its effect on survival of the patients.
💡
Conclusion & Impact:The high coincidence of bladder and prostate cancers should be kept in mind, careful and detailed pathological examinations are needed.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Incidental prostate adenocarcinomas which are detected in radical cystoprostatectomy (RCP) specimens are generally localized, well differentiated and have no clinical importance. In this study, we aimed to determine the rate of incidental prostate adenocarcinoma in patients underwent RCP and assess its effect on survival of the patients. Materials and Methods: The patients who underwent RCP for urothelial bladder cancer between September 2007 and March 2014 were analyzed retrospectively. Deep muscle invasion of urothelial carcinoma or high grade transitional epithelial cell carcinoma that could not be controlled by transurethral resection were the indications for surgery. Standard RCP and bilaterally expanded pelvic lymphadenectomy were performed in all patients. All samples of the cystoprostatectomy specimen were examined; Gleason degree of tumor, concurrent prostatic intraepithelial neoplasia, extracapsular extension, invasion of seminal vesicle, and metastasis of lymph nodes were evaluated. Results: Incidental prostate adenocarcinoma was diagnosed in 26 of 126 patients (20.6%) who underwent RCP for bladder urothelial carcinoma. The stages of prostate cancer were pT2a in 16 patients (61.5%), pT2c in 8 patients (30.7%), and T3b in 2 patients (7.6%). Gleason score was detected as lower than 6 in 18 patients, 7 (4+3) in 6 patients, and 9 (5+4) in 2 patients.Conclusion: All prostate tissue should be resected with no residual prostate tissue left in patients who underwent RCP for bladder cancer. The high coincidence of bladder and prostate cancers should be kept in mind, careful and detailed pathological examinations are needed.

Özet

Amaç: Rastlantısal olarak radikal sistoprostatektomi (RSP) örneklerinde saptanan prostat adenokarsinomlarının çoğu lokalize ve iyi diferansiye klinik önemsiz kanserlerdir. Bu çalışmada R SP yapılan hastalarda rastlantısal saptanan prostat adenokanseri oranını saptamayı ve hastaların sağkalımlarına etkisini ortaya koymayı amaçladık. Gereç ve Yöntem: Eylül 2007 ile Mart 2014 tarihleri arasında mesane kanseri nedeniyle RSP yapılan hastalar retrospektif olarak incelendi. Hastaların cerrahi endikasyonu derin kas invazyonu olan ür otel i yal karsinom veya transüretral rezeksiyon ile kontrol altına alınamayan yüksek dereceli değişici epitel hücreli karsinom olmasıydı. Tüm hastalara standart RSP ve iki taraflı genişletilmiş pelvik lenfadenektomi yapıldı. Sistoprostatektomi materyalinde tüm örnekler dikkate alınarak tümörün Gleason derecesi, prostatik intraepitelyal neoplazi (PIN) birlikteliği, ekstrakapsüler yayılım, seminal vezikül tutulumu ve lenf no du metastazı değerlendirildi. Bulgular: Mesane ürotel i yal kanseri nedeniyle RSP uygulanan 126 hastanın 26’sında (%20.6) rastlantısal prostat adenokanseri saptandı. Saptanan prostat kanserlerinin 16’sı pT2a (%61.5), 8’i T2c (%30.7) ve ikisi de T3b (%7.6) ev resinde idi. Hastaların 18’inin Gleason skoru 6 ve altında, 6’sının 7 (4+3) ve iki hastanın da 9 (5+4) olarak tespit edildi. Sonuç: Mesane kanseri nedeniyle RSP yapılan hastalarda geride prostat dokusu bırakılmadan tüm prostat dokusu çıkarılmalıdır. Mesane ve prostat kanseri birlikteliğinin yüksek olduğu akılda tutulmalı, dikkatli ve detaylı patolojik incelemeye ihtiyaç vardır.

🔖

Cite This Article

TÜRK, H., KARABIÇAK, M., ÜN, S., YALBUZDAĞ, O. N., BAYOL, N. Ü., SÜELÖZGEN, T., İŞOĞLU, C. S., ZORLU, F., TARHAN, H. (2015). Inci dence and clinical importance of prostate cancer in patients who underwent radical cystoprostatectomy. Ege Tıp Dergisi, Cilt: 54 - Sayı: 2, 65–69. https://ajindex.com/articles/222725

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 20 02. CA Cancer J Clin 2005;55(2):74 -108
  2. Türkiye ’ de Prostat Kanseri İnsidansı: Epidemiyolojik bir ç alışma (Prostatürk)
  3. Üroonkoloji Kongresi sunumu; 2009
  4. Damiano R, Di Lorenzo G, Cantiello F, et al. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: An evidence -based analysis. Eur Urol 2007;52(3):648 -57
  5. Gakis G, Schilling D, Bedke J, Sievert KD, Stenzl A. Incidental prostate cancer at radical cystoprostatectomy: Implications for apex -sparing surgery. BJU Int 2010;105(4):468 -71
  6. Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977;20(5):680 -8
  7. Parker SL, Tone T, Bolden S, Wing o PA: Cancer statistics. CA Cancer J Clin 1997;47(1):5 -27
  8. Boyle P, Ferlay J. Cancer incidence and mortality in Europe 2004. Ann Oncol 2005;16(3):481 -8
  9. Zorlu F, Eser SY, Fidaner C. İzmir ilindeki ürogenital kanserlerin insidans hızları. 1995 Üroonkoloji Bülteni 2004;1:2 -9
  10. Holund B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 1980;14(1):29 -35
  11. Franks LM. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68(2):603 -16
  12. Scott R Jr, Mutchnik DL, Laskowski TZ, Schmalhorst WR. Carcinoma of the prostate in elderly men: Incidence, growth characteristics and clinical significance. J Urol 1969;101(1): 602 -7
  13. Polat K, Tüzel E, Aktepe F, Akdoğan B, Güler C, Uzun İ. Türkiye ’ de otopsi serisinde latent prostat kanseri ve yüksek de receli prostatik intraepitelyal neoplazi sıklığının araştırılması. Türk Üroloji Dergisi 2009;35(2):96 -100
  14. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: Incidence, histology and morphometric observations. J Urol 1989;141(5):1091 -94
  15. Chun TY. Coincidence of bladder and prostate cancer. J Urol 1997;157(1):65 -7
  16. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: Implications for possible apical sparing surgery. J Urol 2004;171(2):646 -51
  17. Moutzouris G, Barbatis C, Plastiras D, et al. Incidence and histological findings of unsuspected p rostatic adenocarcinoma in radical cystoprostat